Tag: Cancer: Skin

Updated version simplifies original five-class hierarchy into four classes, including clearly defining classes I and II lesions

Primary tumor ulceration, head/neck location, and Breslow thickness >4 mm predict worse survival in teens

Companies announced that the vaccine performed well in a small study of patients who had the cancer surgically removed

Significantly longer progression-free survival seen with infusion of tumor-infiltrating lymphocytes versus ipilimumab

Significant reduction seen in mortality rate from 2013 to 2017, after the introduction of new treatments in 2011 (most after 2013)

More than twofold increased risk of prostate cancer seen for men with first melanoma diagnosed 10 to 15 years before study recruitment

Quality of life favored the pembrolizumab arm versus standard-of-care arm receiving ipilimumab, high-dose interferon α 2b

Younger age at diagnosis, Clark level II linked to low risk for death among patients with stage I lesions, negative clinical nodes

In phase 2 study, relatlimab and nivolumab combination immunotherapy resulted in pathologic complete response rate of 57 percent

Current evidence is insufficient for assessing balance of benefits and harms of screening for asymptomatic teens, adults